October 1, 2020

Europe Conjugate Vaccine Market to Boost Business Scope with Key Players

The MarketWatch News Department was not involved in the creation of this content.

Sep 13, 2020 (AmericaNewsHour) —
Europe Conjugate Vaccine Market:

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases.Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%. The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.

Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10009588

Market Segmentation:

  • Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.

  • Based on end user, the market is segmented into pediatric and adult.

  • Based on countries, the Europe market is divided into EU5 and Rest of EU.

Key growth factors:

The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.

Threats and key players:

  • The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.

  • Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

  •  Request For Full Report-: https://www.kennethresearch.com/sample-request-10009588

What’s covered in the report?

1. Overview of the Europe conjugate vaccine market

2. Market drivers and challenges in the Europe conjugate vaccine market

3. Market trends in the Europe conjugate vaccine market

4. Historical, current and forecasted market size data for Europe based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume

5. Historical, current and forecasted market size data for Europe based on end user (pediatric and adult conjugate vaccines) – by revenue and by volume

6. Historical, current and forecasted market size data of conjugate vaccines based on countries (EU5, Rest of EU) – by revenue and by volume

7. Historical, current and forecasted market size data for country-wise segments – by revenue and by volume

8. Analysis of the competitive landscape and profiles of major companies operating in the European market

Why buy?

  • Understand the demand for conjugate vaccines to determine the viability of the market

  • Understand the country-specific market size and observations for each segment

  • Develop strategies based on the drivers, trends and highlights for each of the segments

  • Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed

  • Recognize the key competitors of this market and respond accordingly

  • Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth

  • Define the competitive positioning by comparing the products and services with the key players in the market

Request For Full Report-: https://www.kennethresearch.com/sample-request-10009588

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email:  Sales@kennethresearch.com

Phone: +1 313 462 0609

The post Europe Conjugate Vaccine Market to Boost Business Scope with Key Players appeared first on America News Hour.

COMTEX_371205631/2606/2020-09-13T03:59:36

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Source Article